Ameriprise’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.1M | Buy |
1,476,314
+58,191
| +4% | +$1.54M | 0.01% | 994 |
|
|
2025
Q1 | $34.2M | Sell |
1,418,123
-61,473
| -4% | -$1.48M | 0.01% | 1024 |
|
|
2024
Q4 | $59.5M | Buy |
1,479,596
+1,029,125
| +228% | +$41.4M | 0.02% | 751 |
|
|
2024
Q3 | $28.5M | Buy |
450,471
+168,338
| +60% | +$10.7M | 0.01% | 1132 |
|
|
2024
Q2 | $15M | Sell |
282,133
-168,281
| -37% | -$8.92M | ﹤0.01% | 1461 |
|
|
2024
Q1 | $36.8M | Buy |
450,414
+373,373
| +485% | +$30.5M | 0.01% | 948 |
|
|
2023
Q4 | $1.43M | Buy |
+77,041
| New | +$1.43M | ﹤0.01% | 3038 |
|
|
2022
Q1 | – | Sell |
-105,464
| Closed | -$485K | – | 4022 |
|
|
2021
Q4 | $485K | Buy |
+105,464
| New | +$485K | ﹤0.01% | 3535 |
|
|
2020
Q3 | – | Sell |
-47,973
| Closed | -$346K | – | 3789 |
|
|
2020
Q2 | $346K | Sell |
47,973
-34,784
| -42% | -$251K | ﹤0.01% | 3314 |
|
|
2020
Q1 | $387K | Buy |
82,757
+30,925
| +60% | +$145K | ﹤0.01% | 3217 |
|
|
2019
Q4 | $416K | Buy |
51,832
+24,133
| +87% | +$194K | ﹤0.01% | 3394 |
|
|
2019
Q3 | $191K | Buy |
27,699
+4,965
| +22% | +$34.2K | ﹤0.01% | 3558 |
|
|
2019
Q2 | $189K | Buy |
22,734
+8,656
| +61% | +$72K | ﹤0.01% | 3578 |
|
|
2019
Q1 | $140K | Sell |
14,078
-79,252
| -85% | -$788K | ﹤0.01% | 3590 |
|
|
2018
Q4 | $714K | Buy |
93,330
+11,558
| +14% | +$88.4K | ﹤0.01% | 3066 |
|
|
2018
Q3 | $1.42M | Sell |
81,772
-51,292
| -39% | -$893K | ﹤0.01% | 2937 |
|
|
2018
Q2 | $1.25M | Buy |
+133,064
| New | +$1.25M | ﹤0.01% | 2927 |
|